Secretin-stimulated MRCP
- Secretin (administered intravenously) causes exocrine secretion of the pancreas, dilating the pancreatic duct and improving its visualisation; indications include :
- detection/characterisation of pancreatic duct anomalies or strictures
- characterising communications between the pancreatic duct and pseudocysts/fistulas
- characterising pancreatic and sphincter of Oddi dysfunction